🔎 Trials Near Me

Akèy › Kansè nan tete › Ayiti › Honolulu

Etid klinik pou Kansè nan tete nan Honolulu, HI

12 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Honolulu (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Ap rekriteFaz 3
  • Clinical Trial Site, Honolulu
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Ap rekriteFaz 3
  • Kaiser Permanente Moanalua Medical Center, Honolulu
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Ap rekriteEtid obsèvasyon
  • Univercity of Hawaii Cancer Center, Honolulu
Laj 40 ak plis · Fanm · Mizajou Sep 10, 2026 · NCT06672302

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Kaiser Permanente Moanalua Medical Center, Honolulu
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 13 plis
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • Kaiser Permanente Moanalua Medical Center, Honolulu
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

EXoPERT EMERALD Clinical Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Hawaii Cancer Center, Honolulu
Laj 45 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT07186296

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • Spark M. Matsunaga VA Medical Center, Honolulu
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 12 plis
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Center - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 9 plis
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Ap rekriteFaz 1
  • Kapi'olani Medical Center for Women & Children, Honolulu
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT02926690

Etid Kansè nan tete nan lòt vil

Lòt etid nan Honolulu

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.